OUD Provider and Clinical Guidance
Society of Maternal Fetal Medicine Special Report – Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine; 2019
Council on Patient Safety in Women’s Health
Obstetric Care for Women with Opioid Use Disorder Patient Safety Bundle developed by the Alliance for Innovation in Maternal Health (AIM) – a cooperative agreement between the American College of Obstetricians and Gynecologists (ACOG) and the Health and Resources Services Administration Maternal-Child Health Bureau (HRSA-MCHB) – endorsed and disseminated by the Council on Patient Safety in Women’s Health.
Virginia Neonatal Perinatal Collaborative (VPNC)
Maternal OUD & NAS Breakout Session Slides
Virginia Department of Social Services (DSS)
Substance Exposed Infants Manual
Department of Medical Assistance Services (DMAS)
Addiction & Recovery Treatment Services (ARTS)
Virginia Department of Health
- Frequently Asked Questions
- Health Impacts
- Data
- Monitoring & Surveillance
- Primary & Overdose Prevention
- Treatment, Recovery, & Harm Reduction
- Provider Training & Education
- Curb the Crisis
Mandatory Reporting of Substance Exposed Newborns (SEN)
63.2-15093 Code of Virginia: Requires health care providers file a report with CPS if they suspect a child is experiencing withdrawal or was born affected by substance abuse due to in utero drug exposure at Report Substance Exposed Newborn
VA Prescription Monitoring Program (PMP)
Register for the Virginia’s Prescription Monitoring Program (PMP)
If substance use is suspected but not verified by the pregnant woman, you can check the database